The study of Hodgkin lymphoma (HL), with its unique microenvironment and long-term follow-up, has provided exceptional insights into several areas of tumor biology. Findings in HL have not only improved our understanding of human carcinogenesis, but have also pioneered its translation into the clinics. HL is a successful paradigm of modern treatment strategies. Nonetheless, approximately 15–20% of patients with advanced stage HL still die following relapse or progressive disease and a similar proportion of patients are over-treated, leading to treatment-related late sequelae, including solid tumors and organ dysfunction. The malignant cells in HL are characterized by a highly altered genomic landscape with a wide spectrum of genomic alterat...
Purpose: To determine the recurring DNA copy number alterations (CNA) in classical Hodgkin lymphoma ...
Hodgkin lymphoma (HL) is a malignant lymphoma that largely affects young adults and is the second mo...
Aberrant somatic hypermutation (SHM) has been identified as a mechanism for genomewide instability i...
The study of Hodgkin lymphoma (HL), with its unique microenvironment and long-term follow-up, has pr...
Background: Microsatellite and chromosomal instability have been investigated in Hodgkin lymphoma (H...
Background: Microsatellite and chromosomal instability have been investigated in Hodgkin lymphoma (H...
In classical Hodgkin's lymphoma (HL) the malignant mononuclear Hodgkin (H) and multinuclear, diagnos...
In classical Hodgkin’s lymphoma (HL) the malignant mononuclear Hodgkin (H) and multinuclear, diagnos...
Hodgkin lymphoma (HL) is a malignant lymphoma that is diagnosed mostly in young adults, and is the s...
Anticancer regimens for Hodgkin lymphoma (HL) patients include highly genotoxic drugs that have been...
Hodgkin's lymphoma (HL) is a lymphoid malignancy representing 5% of all cancers in children, 16% in ...
In classical Hodgkin lymphoma (cHL) the mechanisms underlying primary refrac-tory disease and relaps...
Hodgkin\u2019s lymphoma (HL) is a heterogeneous lymphoid malignancy curable in more than 80% of case...
Hodgkin lymphoma (HL) is a biologically diverse group of lymphoid tumors, which accounts for 1% of a...
Hodgkin- and Reed-Sternberg (HRS) cells microdissected from 41 classical Hodgkin lymphomas (cHL) of ...
Purpose: To determine the recurring DNA copy number alterations (CNA) in classical Hodgkin lymphoma ...
Hodgkin lymphoma (HL) is a malignant lymphoma that largely affects young adults and is the second mo...
Aberrant somatic hypermutation (SHM) has been identified as a mechanism for genomewide instability i...
The study of Hodgkin lymphoma (HL), with its unique microenvironment and long-term follow-up, has pr...
Background: Microsatellite and chromosomal instability have been investigated in Hodgkin lymphoma (H...
Background: Microsatellite and chromosomal instability have been investigated in Hodgkin lymphoma (H...
In classical Hodgkin's lymphoma (HL) the malignant mononuclear Hodgkin (H) and multinuclear, diagnos...
In classical Hodgkin’s lymphoma (HL) the malignant mononuclear Hodgkin (H) and multinuclear, diagnos...
Hodgkin lymphoma (HL) is a malignant lymphoma that is diagnosed mostly in young adults, and is the s...
Anticancer regimens for Hodgkin lymphoma (HL) patients include highly genotoxic drugs that have been...
Hodgkin's lymphoma (HL) is a lymphoid malignancy representing 5% of all cancers in children, 16% in ...
In classical Hodgkin lymphoma (cHL) the mechanisms underlying primary refrac-tory disease and relaps...
Hodgkin\u2019s lymphoma (HL) is a heterogeneous lymphoid malignancy curable in more than 80% of case...
Hodgkin lymphoma (HL) is a biologically diverse group of lymphoid tumors, which accounts for 1% of a...
Hodgkin- and Reed-Sternberg (HRS) cells microdissected from 41 classical Hodgkin lymphomas (cHL) of ...
Purpose: To determine the recurring DNA copy number alterations (CNA) in classical Hodgkin lymphoma ...
Hodgkin lymphoma (HL) is a malignant lymphoma that largely affects young adults and is the second mo...
Aberrant somatic hypermutation (SHM) has been identified as a mechanism for genomewide instability i...